Abstract
Background Risk stratification is important in patients with postcardiac arrest syndrome (PCAS). The post-Cardiac Arrest Syndrome for Therapeutic hypothermia (CAST) and revised CAST (rCAST) scores have been well validated for predicting the accuracy of neurological outcomes, particularly for conventionally resuscitated PCAS patients. However, no studies have evaluated patients undergoing extracorporeal cardiopulmonary resuscitation (ECPR).
Methods Adult patients with out-of-hospital cardiac arrest (OHCA) who underwent ECPR were analyzed in this retrospective observational multicenter cohort study (SAVE-J II study). We validated the accuracy of the CAST and rCAST scores for predicting favorable neurological outcomes (cerebral performance category 1 or 2) at 30 days. Moreover, we compared the predictive performance of these CAST/rCAST scores with those of the previously documented TiPS65 risk model derived from patients with OHCA who were resuscitated using ECPR.
Results A total of 1135 patients were analyzed. Their median age was 60 years and males comprised 84% of the cohort. The proportion of patients with favorable neurological outcomes was 16.6% overall. In the external validation, the area under the curve (AUC) of the CAST score was numerically larger than those of the rCAST and TiPS65 scores (AUC 0.677 vs. 0.603: p < 0.001, vs. 0.633: p = 0.154, respectively). Both CAST/rCAST risk scores showed good calibration (Hosmer– Lemeshow test: p = 0.726 and 0.674, respectively). Furthermore, the CAST score showed significantly better predictability in net reclassification than did the rCAST (p < 0.001) and TiPS65 scores (p = 0.001).
Conclusions CAST and rCAST scores can predict neurological outcomes in patients with OHCA who undergo ECPR. The prognostic accuracy of the CAST score was significantly better than that of other pre-existing risk prediction models.
IRB information The present study was approved by the institutional review board of Kagawa University (approval number: 2018-110)
Clinical trial registration https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041577 (unique identifier: UMIN000036490)
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041577 (unique identifier: UMIN000036490)
Funding Statement
Japan Society for the Promotion of Science (JSPS) KAKENHI (Grant?in?Aid for Scientific Research [C]) Grant Number JP19K09419.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Kagawa University Institutional Ethics Committee (approval number: 2018-110) and by that of each participating institution. This secondary analysis of de-identified data was approved by the Institutional Review Board of the Saiseikai Utsunomiya Hospital (approval number: 2023-01).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Raw data were generated at Saiseikai Utsunomiya Hospital. Derived data supporting the findings of this study are available from the corresponding author KM on request.
